Erlotinib for advanced non–small-cell lung cancer in the elderly: an analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR. 21

P Wheatley-Price, K Ding, L Seymour… - Journal of Clinical …, 2008 - ascopubs.org
Purpose National Cancer Institute of Canada Clinical Trials Group Study BR. 21 established
erlotinib as a standard of care in patients with non–small-cell lung cancer (NSCLC) after …
被引用次数：314 相关文章
[PDF] researchgate.net

[PDF][PDF] Erlotinib for Advanced Non–Small-Cell Lung Cancer in the Elderly: An Analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR. 21

P Wheatley-Price, K Ding, L Seymour, GM Clark… - J Clin …, 2008 - researchgate.net
Purpose National Cancer Institute of Canada Clinical Trials Group Study BR. 21 established
erlotinib as a standard of care in patients with non–small-cell lung cancer (NSCLC) after …

[引用][C] Erlotinib for Advanced Non-Small-Cell Lung Cancer in the Elderly: An Analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR. 21

P WHEATLEY-PRICE, K DING… - Journal of clinical …, 2008 - pascal-francis.inist.fr
Erlotinib for Advanced Non-Small-Cell Lung Cancer in the Elderly : An Analysis of the National
Cancer Institute of Canada Clinical Trials Group Study BR.21 CNRS Inist Pascal-Francis CNRS …

Erlotinib for Advanced Non–Small-Cell Lung Cancer in the Elderly: An Analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR. 21

P Wheatley-Price, K Ding, L Seymour… - Journal of Clinical …, 2008 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Purpose</jats: title>< jats: p> National Cancer Institute of
Canada Clinical Trials Group Study BR. 21 established erlotinib as a standard of care in …

Erlotinib for advanced non-small-cell lung cancer in the elderly: an analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR. 21.

P Wheatley-Price, K Ding, L Seymour… - Journal of Clinical …, 2008 - europepmc.org
Purpose National Cancer Institute of Canada Clinical Trials Group Study BR. 21 established
erlotinib as a standard of care in patients with non-small-cell lung cancer (NSCLC) after …

Erlotinib for advanced non-small-cell lung cancer in the elderly: an analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR. 21

P Wheatley-Price, K Ding… - Journal of clinical …, 2008 - pubmed.ncbi.nlm.nih.gov
Purpose National Cancer Institute of Canada Clinical Trials Group Study BR. 21 established
erlotinib as a standard of care in patients with non-small-cell lung cancer (NSCLC) after …

[引用][C] Erlotinib for Advanced Non-Small-Cell Lung Cancer in the Elderly: An Analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR. 21

P WHEATLEY-PRICE, K DING… - Journal of …, 2008 - American Society of Clinical …